Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Secondary OPINION analysis boosts safety profile of maintenance olaparib for ovarian cancer

29 Apr 2022 bởi

In women with platinum-sensitive relapsed ovarian cancer without a deleterious or suspected deleterious germline BRCA1/BRCA2 mutation (non-gBRCAm), maintenance olaparib was well tolerated, according to the secondary safety results from the phase IIIb OPINION study presented at SGO 2022.

29 Apr 2022

Should intraperitoneal chemo be reconsidered for ovarian cancer?

28 Apr 2022 bởi

Progression-free survival (PFS) is significantly longer with intraperitoneal (IP) over intravenous (IV) carboplatin, when combined with dose-dense paclitaxel, in patients with ovarian, fallopian tube, or primary peritoneal cancer, regardless of residual tumour size after initial surgery, according to the phase III iPocc* trial presented at SGO 2022.

28 Apr 2022

Infertility ups risk of heart failure in women

25 Apr 2022

A history of infertility among women appears to contribute to an increased risk of incident heart failure (HF), reveals a recent study.

25 Apr 2022

CHAP backs BP control during pregnancy, even for mild hypertension

23 Apr 2022 bởi

Actively treating even mild hypertension to a target blood pressure (BP) of <140/90 mm Hg in pregnant women significantly lowers the risk of adverse pregnancy outcomes without apparent harm to the foetus compared with a strategy of reserving treatment to only when hypertension becomes severe (≥160/105 mm Hg), according to the CHAP* study presented at ACC 2022.

23 Apr 2022

Tislelizumab a potential treatment alternative for gynaecologic MSI-H/dMMR tumours

20 Apr 2022 bởi

The humanized IgG4 monoclonal antibody tislelizumab was clinically active in women with gynaecologic microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) solid tumours, and was generally well-tolerated with no new safety signals, according to a subgroup analysis of the phase II RATIONALE 209 study presented at SGO 2022.

20 Apr 2022

Higher dietary inflammation potential linked to polycystic ovary syndrome

18 Apr 2022

Women who consume foods with greater inflammation potential in high amounts are more likely to have polycystic ovary syndrome (PCOS), a study has found.

18 Apr 2022

Maintenance selinexor promising for PFS in advanced/recurrent endometrial cancer

14 Apr 2022 bởi

Maintenance treatment with selinexor improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer who had previously received first-line chemotherapy, particularly those with endometrioid histology and wild-type p53, according to a study presented at SGO 2022.

14 Apr 2022

First-line niraparib maintenance regimen boosts PFS in advanced ovarian cancer

11 Apr 2022 bởi

First-line maintenance therapy with niraparib at an individualized starting dose (ISD) improved progression-free survival (PFS) in patients with newly diagnosed advanced ovarian cancer, according to results of the phase III PRIME study presented at SGO 2022.

11 Apr 2022

MIRV shows promise in platinum-resistant ovarian cancer

09 Apr 2022 bởi

The first-in-class antibody-drug conjugate mirvetuximab soravtansine (MIRV) shows promising anti-tumour activity in previously treated patients with platinum-resistant ovarian cancer who express high levels of folate receptor alpha (FRα), according to the SORAYA study presented at SGO 2022.

09 Apr 2022

SARS-CoV-2 tied to increased obstetric-related morbidity, mortality

08 Apr 2022 bởi

SARS-CoV-2 infection during pregnancy or the postpartum period is tied to an increased risk of maternal mortality or serious morbidity due to obstetric complications, a study from the US showed.

08 Apr 2022